Michael Franken, President, Biosimilars Busines at MOMENTA PHARMACEUTICALS INC (MNTA), sold 520 shares at $15.84 ($8K) on 2015-12-11, disclosed to the SEC on 2015-12-14.
Scheduled sale ($8k) by President, Biosimilars Busines under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2015-06-15 | $11K | — | Filing → |
| MNTA | SELL | 2015-03-13 | $8K | — | Filing → |
| MNTA | SELL | 2014-12-12 | $25K | — | Filing → |